Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: Emcure | Rare Historical Photos

Emcure Pharma gets CDSCO nod to market Poviztra for fatty liver treatment

Emcure Pharmaceuticals announced its brand Poviztra is now available for fatty liver treatment. This follows regulatory approval for treating metabolic dysfunction-associated steatohepatitis in adults. Poviztra contains innovator semaglutide manufactured in Europe by Novo Nordisk. The approval expands access to treatment for this progressive liver disease. This marks a significant milestone…

The Economic Times · Jul 20

PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake

PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake

Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.

The Economic Times · Jun 9

Public money, private patents? Unravelling India’s opacity over its Covid vaccines

Public money, private patents? Unravelling India’s opacity over its Covid vaccines

Public money, private patents: Unravelling India’s opacity over its Covid vaccines

Newslaundry · Mar 25, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

1

Coverage From

Organisations

Washington University

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play